DexCom (NASDAQ: DXCM ) has been unable to recover from its disastrous Q2 earnings it published a quarter ago, where it surprised everyone with its abysmal outlook for the rest of the year.Uttam is a growth-oriented investment analyst whose equity research primarily focuses on the technology sector. Semiconductors, Artificial Intelligence and Cloud software are some of the key sectors that are regularly researched and published by him. His research also focuses on other areas such as MedTech, Defense Tech, a ...